Changes in plasma biomarkers following treatment with cabozantinib in metastatic castration-resistant prostate cancer: a post hoc analysis of an extension cohort of a phase II trial

Overview of attention for article published in Journal of Translational Medicine, January 2016

Altmetric Badge

Mentioned by

twitter: 2 X users

Citations

dimensions_citation: 21 Dimensions

Readers on

mendeley: 41 Mendeley

Summary X Dimensions citations

So far, Altmetric has seen 2 X posts from 2 X users, with an upper bound of 789 followers.

Changes in plasma biomarkers following treatment with cabozantinib in metastatic castration-resistant prostate… https://t.co/mkx7dUOFRx

Reply Repost Favourite

Changes in plasma biomarkers following treatment with cabozantinib in metastatic… https://t.co/SNpxweFJ8U #JTransMed

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.